Pfizer (PFE)
23.98
+0.05 (0.21%)
NYSE · Last Trade: Aug 7th, 10:42 AM EDT
Wall Street Has Mixed Opinions On Future Of Arvinas’ Investigational Drug: Retail’s Got A Cautious Approachstocktwits.com
Via Stocktwits · August 7, 2025
Meeting its dividend commitment this year should be a breeze, but the path ahead is much harder to predict.
Via The Motley Fool · August 7, 2025
A surge in private market investment has investors wondering: Is it time to bet bigger on biotech?
Via The Motley Fool · August 6, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active S&P500 stocks in today's session.
Via Chartmill · August 6, 2025
Trump tweets trigger major stock swings for companies like Tesla, Boeing, Pfizer. Democrats demand an investigation.
Via Benzinga · August 6, 2025
How does $740 in annual income sound?
Via The Motley Fool · August 6, 2025
The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million.
Via Benzinga · August 6, 2025
US stock futures rose on Wed. after falling on Thurs. Trump threatened tariffs on imported pharma up to 250%. Bond yields down & Fed may cut rates.
Via Benzinga · August 6, 2025
The results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance.
Via Stocktwits · August 6, 2025
President Donald Trump has indicated the possibility of imposing tariffs on imported pharmaceuticals that could rise up to 250%, indicating the highest rate he has proposed so far.
Via Benzinga · August 6, 2025
Via Benzinga · August 6, 2025
A weaker-than-expected ISM services report reignited fears of a slowing U.S. economy, dragging major indices into the red.
Via Chartmill · August 6, 2025
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZenecastocktwits.com
Via Stocktwits · August 5, 2025
The large pharmaceutical company reported strong second-quarter earnings results.
Via The Motley Fool · August 5, 2025
Amgen crushed second-quarter forecasts late Tuesday. The news could push Amgen stock into a breakout.
Via Investor's Business Daily · August 5, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.
Via Chartmill · August 5, 2025
Pfizer In Talks With Trump Administration Regarding Lower Drug Prices And Tariffs, Says CEO: Stock Rallies On Improved Full-Year Guidance, Upbeat Q2 Reportstocktwits.com
Via Stocktwits · August 5, 2025
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · August 5, 2025
Palantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Todaystocktwits.com
Via Stocktwits · August 5, 2025
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc.
Via Benzinga · August 5, 2025
TSMC stock fall on news of suspected trade secrets theft at the semiconductor manufacturing powerhouse, a major player in the AI chip market.
Via Investor's Business Daily · August 5, 2025
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.
Via Chartmill · August 5, 2025
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.
Via Chartmill · August 5, 2025
Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78.
Via Talk Markets · August 5, 2025